{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:06Z","timestamp":1772165586968,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) is prevalent, especially in patients with heart failure. Their prevalence increases with age and both conditions are interrelated. Electrocardioversion (ECV) is considered a safe and effective procedure and is among one of the recommended therapies to terminate AF back to normal sinus rhythm. Our study highlights one of the rare complications following ECV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 71-year-old female with a history of atrial fibrillation underwent electrocardioversion and developed sudden onset of ventricular stunning resulting in refractory cardiogenic shock. She was treated with mechanical cardiac support including IABP and Impella. Both provided minimal support then rapid clinical deterioration happened leading to imminent death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with atrial fibrillation and heart failure treated with electrocardioversion might develop refractory cardiogenic shock and death as a complication of this procedure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03376-8","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T14:02:22Z","timestamp":1689343342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Shocked to death: a case report of cardiogenic shock and death following electrocardioversion for atrial fibrillation"],"prefix":"10.1186","volume":"23","author":[{"given":"Anas Mohamad","family":"Hashem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Al Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Khalouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shehadah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moghniuddin","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryrose","family":"Laguio-Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"3376_CR1","doi-asserted-by":"publisher","unstructured":"Circulation. 2021;143(8):e254-e743. https:\/\/doi.org\/10.1161\/CIR.0000000000000950.","DOI":"10.1161\/CIR.0000000000000950"},{"issue":"14","key":"3376_CR2","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2020","unstructured":"Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2020;24(14):1555\u201366. https:\/\/doi.org\/10.1177\/2047487317715769.","journal-title":"Eur J Prev Cardiol"},{"issue":"23","key":"3376_CR3","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920\u20135.","journal-title":"Circulation"},{"issue":"23","key":"3376_CR4","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","volume":"98","author":"PC Deedwania","year":"1998","unstructured":"Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation. 1998;98(23):2574\u20139.","journal-title":"Circulation"},{"issue":"7","key":"3376_CR5","doi-asserted-by":"publisher","first-page":"e000078","DOI":"10.1161\/HAE.0000000000000078","volume":"14","author":"R Gopinathannair","year":"2021","unstructured":"Gopinathannair R, Chen LY, Chung MK, et al. Managing Atrial Fibrillation in patients with heart failure and reduced ejection Fraction: A Scientific Statement from the American Heart Association. Circulation: Arrhythmia and Electrophysiology. 2021;14(7):e000078. https:\/\/doi.org\/10.1161\/HAE.0000000000000078.","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"3376_CR6","doi-asserted-by":"publisher","unstructured":"Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516-25. https:\/\/doi.org\/10.1161\/circulationaha.108.821306.","DOI":"10.1161\/circulationaha.108.821306"},{"issue":"15","key":"3376_CR7","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","volume":"13","author":"R Gopinathannair","year":"2015","unstructured":"Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-Induced Cardiomyopathies: mechanisms, Recognition, and management. J Am Coll Cardiol. 2015;13(15):1714\u201328. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.038.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3376_CR8","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation. 2019;140(2):e125\u201351. https:\/\/doi.org\/10.1161\/CIR.0000000000000665.","journal-title":"Circulation"},{"key":"3376_CR9","doi-asserted-by":"publisher","unstructured":"Bonfanti L, Annovi A, Sanchis-Gomar F, et al. Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience. Clin Exp Emerg Med. 2019;6(1):64\u20139. https:\/\/doi.org\/10.15441\/ceem.17.286.","DOI":"10.15441\/ceem.17.286"},{"issue":"11","key":"3376_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cjca.2021.08.018","volume":"37","author":"IG Stiell","year":"2021","unstructured":"Stiell IG, Eagles D, Nemnom MJ, et al. Adverse events Associated with Electrical Cardioversion in patients with Acute Atrial Fibrillation and Atrial Flutter. Can J Cardiol 2021;37(11):1775\u201382. https:\/\/doi.org\/10.1016\/j.cjca.2021.08.018.","journal-title":"Can J Cardiol Nov"},{"key":"3376_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.hlc.2016.06.323","volume":"25","author":"P Venkataraman","year":"2016","unstructured":"Venkataraman P, Koshy A, Teh A, Chou B. <strong> A Case Report of Severe Myocardial Stunning and Death Following Electro-Cardioversion (ECV) for Atrial Flutter<\/strong>. Heart Lung and Circulation. 2016;25:135\u2013S136. https:\/\/doi.org\/10.1016\/j.hlc.2016.06.323.","journal-title":"Heart Lung and Circulation"},{"issue":"2","key":"3376_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1152\/physrev.1999.79.2.609","volume":"79","author":"R Bolli","year":"1999","unstructured":"Bolli R, Marb\u00e1n E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev Apr. 1999;79(2):609\u201334. https:\/\/doi.org\/10.1152\/physrev.1999.79.2.609.","journal-title":"Physiol Rev Apr"},{"key":"3376_CR13","doi-asserted-by":"publisher","first-page":"881446","DOI":"10.3389\/fcvm.2022.881446","volume":"9","author":"A Younis","year":"2022","unstructured":"Younis A, Nehoray N, Glikson M, et al. QTc Dynamics following Cardioversion for Persistent Atrial Fibrillation. Front Cardiovasc Med. 2022;9:881446. https:\/\/doi.org\/10.3389\/fcvm.2022.881446.","journal-title":"Front Cardiovasc Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03376-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T14:02:53Z","timestamp":1689343373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03376-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03376-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2561055\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient\u2019s next of kin in line with COPE guidance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"We attest that informed consent was obtained from the patient\u2019s next of kin for publication of identifying information\/images in an online open-access publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"2014: Diagnosed with atrial fibrillation, treated with metoprolol. June\/2021: Patient developed tachycardia-induced cardiomyopathy, underwent electrocardioversion. Unsuccessful. July\/2021: She underwent catheter ablation for recurrent atrial fibrillation, reverted to normal sinus rhythm. September\/2021 (Day 1 of admission): She presented with sudden onset of dyspnea and palpitations, diagnosed with atrial fibrillation and rapid ventricular response requiring cardioversion. Initiated on pharmacological cardioversion and then advanced to electrical cardioversion. She decompensated and bedside TTE showed severe global hypokinesis with ventricular stunning. She was diagnosed with cardiogenic shock and placed on pressors. Day 2: Left and Right heart catheterization showed normal coronary arteries with moderate pulmonary hypertension, low CO\/CI and elevated SVR confirming cardiogenic shock. Patient was placed on IABP. Day 3: Due to lack of hemodynamic improvement, patient was switched to Impella 2.5 instead of IABP. Patient was maximized on pressors. Day 4: Goals of care discussion with the family, they pursued comfort care measures and patient ultimately passed away.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Event Timeline"}}],"article-number":"350"}}